Published in BMJ on March 17, 1990
Community obstetric care in West Berkshire. BMJ (1991) 3.44
Contribution of general practitioners to hospital intrapartum care in maternity units in England and Wales in 1988. BMJ (1991) 2.16
Choice and chance in low risk maternity care. BMJ (1991) 1.63
What is interface audit? J R Soc Med (1994) 1.41
Outcome of planned home births in an inner city practice. BMJ (1991) 1.27
A natural survey of audit activity across the primary-secondary care interface. Qual Health Care (1996) 1.17
General practitioner obstetrics in Bradford. BMJ (1990) 0.75
Interface flow process audit: using the patient's career as a tracer of quality of care and of system organisation. Int J Integr Care (2004) 0.75
General practitioner maternity units. BMJ (1990) 0.75
General practitioner obstetrics in Bradford. BMJ (1990) 0.75
Community obstetric care. BMJ (1991) 0.75
Community dermatology. BMJ (1993) 0.75
General practice obstetrics in Bradford. BMJ (1990) 0.75
General practice obstetrics in Bradford. BMJ (1990) 0.75
Comparison of outcome of low-risk labour in an isolated general practice maternity unit and a specialist maternity hospital. J R Coll Gen Pract (1987) 3.63
General practitioner obstetrics. BMJ (1989) 2.99
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol (1999) 3.62
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group. J Clin Oncol (2000) 2.73
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol (1997) 2.17
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer (1976) 1.85
Changing the pattern out of hours: a survey of general practice cooperatives. BMJ (1997) 1.80
An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med (1985) 1.77
Endocrine treatment options for advanced breast cancer--the role of fulvestrant. Eur J Cancer (2005) 1.65
Scar formation after stereotactic vacuum-assisted core biopsy of benign breast lesions. Clin Radiol (2006) 1.60
Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer (1996) 1.59
Preoperative prediction of postoperative deep vein thrombosis. Br Med J (1976) 1.58
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med (1979) 1.57
Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J Med Virol (1985) 1.55
Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. J Gen Virol (1983) 1.53
Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group. Ann Intern Med (1993) 1.50
Non-Hodgkin's lymphomas. I. Bone marrow involvement. Cancer (1972) 1.49
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Annual patterns in bacterioplankton community variability in a humic lake. Microb Ecol (2004) 1.43
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
Guidelines for systemic therapy of early stage breast cancer. Breast Cancer Res Treat (1997) 1.42
Amino acid transport in human and in sheep erythrocytes. Proc R Soc Lond B Biol Sci (1980) 1.41
Early stage cervical cancer: psychosocial and sexual outcomes of treatment. Br J Cancer (1993) 1.40
Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer (1975) 1.39
Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther (1997) 1.39
Initial experience of intramammary prostheses in breast conservation surgery. Eur J Surg Oncol (1999) 1.38
Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys (1996) 1.35
Systematic restaging in patients with Hodgkin's disease: a Southwest Oncology Group Study. Cancer (1978) 1.30
Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. J Gen Virol (1994) 1.26
Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. J Hum Virol (2002) 1.25
In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol (1993) 1.20
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol (1986) 1.19
Involvement of the central nervous system by non-Hodgkin's lymphoma: the Southwest Oncology Group experience. Cancer (1979) 1.17
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Cancer (1973) 1.14
Non-Hodgkin's lymphomas. II. Single agent chemotherapy. Cancer (1972) 1.12
Non-Hodgkin's lymphomas. V. Results of radiotherapy. Cancer (1973) 1.11
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst (1993) 1.11
Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study. Ann Intern Med (1994) 1.07
In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br J Pharmacol (1991) 1.07
Analgesia after herniotomy in a paediatric day unit. Br Med J (Clin Res Ed) (1982) 1.07
In vivo structure-function analysis of Drosophila Hairless. Mech Dev (1997) 1.06
Indium-111 bleomycin tumor scanning in lymphoma. Med Pediatr Oncol (1975) 1.04
Chemotherapy of localised histiocytic lymphoma. Lancet (1979) 1.04
Medical illness in psychiatric patients: barriers to diagnosis and treatment. South Med J (1982) 1.03
Antioxidant activity of flavonoids: efficiency of singlet oxygen (1 delta g) quenching. J Photochem Photobiol B (1993) 1.00
Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial. Recent Results Cancer Res (1982) 0.99
Voxel-based morphometric MRI post-processing in MRI-negative focal cortical dysplasia followed by simultaneously recorded MEG and stereo-EEG. Epilepsy Res (2012) 0.99
Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int (1997) 0.99
Hypersensitivity to procarbazine (Matulane) manifested by fever and pleuropulmonary reaction. Cancer (1972) 0.99
In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium. Br J Pharmacol (1992) 0.99
Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Br J Pharmacol (1995) 0.99
School policy and environment: results from the School Health Policies and Programs Study 2000. J Sch Health (2001) 0.99
Genital herpes. Arch Dis Child (1983) 0.99
Breaking down barriers: multidisciplinary education model. J Allied Health (1997) 0.98
Characterisation of kinin receptors on the human isolated umbilical artery. J Endocrinol (1998) 0.97
Immunohistological detection of Legionella pneumophila in lung sections. J Clin Pathol (1987) 0.97
Effect of cigarette smoking on subsequent postoperative thromboembolic disease in gynaecological patients. Br Med J (1978) 0.97
Using decision analysis to calculate the optimum treatment for microinvasive cervical cancer. Br J Cancer (1992) 0.97
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol (1995) 0.96
Conception during 'Diane' therapy--a successful outcome. Br J Dermatol (1985) 0.96
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas. Semin Hematol (1987) 0.96
Development and use of a natural history data base of breast cancer studies. Am J Clin Oncol (1987) 0.95
Non-Hodgkin's lymphomas. 3. Preliminary results of radiotherapy and a proposal for new clinical trials. Radiology (1972) 0.95
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. Clin Transplant (2000) 0.95
Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study. Cancer Treat Rep (1982) 0.95
Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer (1981) 0.94
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting. Cancer Treat Rev (1982) 0.94
Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid. Lancet (1983) 0.94
Rokitansky-Kuster-Hauser syndrome associated with chromosomal abnormality and fibroid arising from the rudimentary uterine horn. J Obstet Gynaecol (2000) 0.94
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. Cancer (1976) 0.93
Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol (1984) 0.93
Development of a bioassay for putative human lymphoma stem cells. Blood (1979) 0.92
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer (1979) 0.92
Clinical correlations of drug sensitivity in the human tumor stem cell assay. Recent Results Cancer Res (1980) 0.92
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study. Cancer (1983) 0.91
Adenovirus-mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett (1994) 0.91
Characterization of cell death pathways in murine retinal neurodegeneration implicates cytochrome c release, caspase activation, and bid cleavage. Mol Cell Neurosci (2001) 0.91
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. Cancer Treat Rep (1977) 0.91
Nabilone: a potent antiemetic cannabinol with minimal euphoria. Biomedicine (1977) 0.91
Glycine transport in human erythrocytes. J Physiol (1981) 0.91
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer. J Clin Oncol (1998) 0.91
Computed tomographic scanning in patients with lymphoma. Cancer (1978) 0.90
Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer (1977) 0.90
Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood (1983) 0.89
The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group. Blood (1982) 0.89
Time and frequency domain characteristics of sperm whale clicks. J Acoust Soc Am (1995) 0.88